Immunological Evidence for the Requirement of Sepiapterin Reductase for Tetrahydrobiopterin Biosynthesis in Brain

Publisher Website
Google Scholar
Abstract
Specific antibodies to sepiapterin reductase were used to investigate its involvement in de novo (6R)‐5,6,7,8‐tetrahydrobiopterin (BH4) biosynthesis in rat brain. Antisepiapterin reductase (anti‐SR) serum totally inhibited NADPH‐dependent sepiapterin reductase activity in supernatants from discrete rat brain areas and liver. The anti‐SR serum also inhibited the conversion of 7,8‐dihydroneopterin triphosphate to BH4 in rat brain extracts. The inhibition was accompanied by a concentration‐dependent increase in the formation of 6‐lactoyltetrahydropterin (6LPH4), a proposed intermediate in BH4 biosynthesis. In addition, anti‐SR serum was used to characterize the distribution and molecular properties of sepiapterin reductase in rat tissues. Sodium dodecyl sulfate‐polyacrylamide gel electrophoresis followed by Western blotting indicated that there was a single polypeptide with the same molecular weight (28,000) as that of the subunit of pure sepiapterin reductase present in all tissues examined except for liver, where an immunoreactive protein of higher molecular weight (30,500) also was detected. Two‐dimensional gel electrophoresis of rat striatum and liver demonstrated that the isoelectric point of sepiapterin reductase from both tissues was 6.16 and that the higher molecular weight immunoreactive material in liver had an isoelectric point of 7.06. Our studies with specific anti‐SR serum confirmed the results of previous studies using chemical inhibitors of sepiapterin reductase, which suggested that sepiapterin reductase activity was essential for BH4 biosynthesis in the CNS and that 6LPH4 could be a precursor of BH4.